I. Yildiz Et Al. , "Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey," JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12, pp.1380-1387, 2011
Yildiz, I. Et Al. 2011. Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey. JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12 , 1380-1387.
Yildiz, I., Sen, F., Basaran, M., Ekenel, M., Agaoglu, F., Darendeliler, E., ... Tunc, H. M.(2011). Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey. JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12, 1380-1387.
Yildiz, Ibrahim Et Al. "Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey," JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12, 1380-1387, 2011
Yildiz, Ibrahim Et Al. "Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey." JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12, pp.1380-1387, 2011
Yildiz, I. Et Al. (2011) . "Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey." JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.12, pp.1380-1387.
@article{article, author={Ibrahim Yildiz Et Al. }, title={Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey}, journal={JAPANESE JOURNAL OF CLINICAL ONCOLOGY}, year=2011, pages={1380-1387} }